A new study found that weight-loss medications like Ozempic and Mounjaro are not as effective in a “real-world” setting ...

Key Takeaways Real-world results with weight-loss drugs aren’t as impressive as those in clinical trialsClinic patients ...

A clash is brewing between doctors and patients when it comes to treatment for sleep apnea in those with obesity, a new study ...

Researchers found that injectable GLP-1 receptor agonists for obesity tended to yield smaller reductions in weight in ...

“In real-world terms, that means many patients ... “We now have more than one highly effective option, and Zepbound seems to be leading the pack,” he said. An important implication, for ...

Injectable GLP-1 drugs for obesity have been found to produce smaller weight loss in a real-world setting compared to ...

June 9 (UPI) A clash is brewing between doctors and patients when it comes to treatment for sleep apnea in those with obesity, a new study reports. Doctors favor treatment with continuous positive ...

“The results highlight a need for real-world comparative effectiveness data of CPAP ... the U.S. Food and Drug Administration (FDA) approved Zepbound as the first drug to treat people with ...

But patients would rather treat their sleep apnea with tirzepatide (Zepbound), a GLP-1 weight-loss drug, researchers found. "The results highlight a need for real-world comparative effectiveness ...

Researchers found that injectable GLP-1 receptor agonists for obesity tended to yield smaller reductions in weight in real-world settings ... have access to effective anti-obesity medications.